Seth Whitelaw, J.D., LL.M, S.J.D.Senior Fellow & Adjunct Professor, Life Science Compliance at Mitchell Hamline School of Law
Dr. Whitelaw has almost 30 years of industry experience in the life sciences and health care sectors, as an attorney, compliance officer (C.R. Bard, Inc., GlaxoSmithKline, and Misonix, Inc.) and industry consultant (Deloitte, Whitelaw Compliance Group LLC.). Most recently, he served as a compliance expert in the Opioid MDL litigation.
In addition to being a Food and Drug Law Institute (FDLI) fellow and having worked for both the FDA’s Office of Chief Counsel, he has a J.D. from Washington & Lee School of Law, an LL.M. from George Washington University Law School, and a doctorate in Health Law from Widener University School of Law.
Currently, Dr. Whitelaw is the Editor of the Policy & Medicine Compliance Update and teaches corporate governance and compliance at Mitchell Hamline School of Law where he is the Senior Fellow & Adjunct Professor, Life Sciences Compliance.